Clinical Trials List
2006-08-01 - 2009-01-31
Phase III
Terminated9
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 吳惠東 Division of Thoracic Medicine
- 陳冠宇 Division of Thoracic Medicine
- Chong-Jen Yu Division of Thoracic Medicine
- 鄭之勛 Division of Thoracic Medicine
- 李佩玲 Division of Thoracic Medicine
- Ping-Hung Kuo Division of Thoracic Medicine
- 廖唯昱 Division of Thoracic Medicine
- PAN-CHYR YANG Division of Thoracic Medicine
- Shih-Chi Ku Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chung-Chi Huang Division of Thoracic Medicine
- 胡漢忠 Division of Thoracic Medicine
- Meng-Jer Hsieh Division of Thoracic Medicine
- Ning-Hung Chen Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chien-Chung Lin Division of Thoracic Medicine
- Chang-Wen Chen Division of Thoracic Medicine
- 陳炯睿 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- jong rung Tsai Division of Thoracic Medicine
- 王東衡 Division of Thoracic Medicine
- Jen-Yu Hung Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
140 participants
-
Global
3300 participants
